Icarus Medical Secures $7.2 Million Series A to Accelerate Growth and Innovation

Icarus Medical develops innovative orthotic technologies designed to improve mobility, reduce pain, and help patients return to the activities they love.
Charlottesville-based med-tech company accelerates innovation and commercialization in orthopedic technology
Proceeds from the financing will support accelerated commercialization across the US, continued product development, manufacturing expansion, clinical validation of current devices, and personnel development as the company continues increasing its national presence.
Major investors participating in the round include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors. In addition to capital, these partners bring strategic healthcare, commercialization, operational expertise, and industry relationships that will help support Icarus Medical’s next stage of development.
“This financing represents a major milestone for Icarus Medical and validates both the clinical impact of our technology and the strength of the team we have built,” said Dave Johnson, Founder and CEO of Icarus Medical. “We are excited to partner with investors who not only believe in our mission, but who also bring strategic insight and relationships that can help accelerate our trajectory.”
Founded in Charlottesville, Icarus Medical is developing a new class of orthopedic bracing technologies that combine biomechanics, additive manufacturing, and patient-focused design to help people stay active and mobile while reducing pain and improving function. The company’s technologies include the Ascender Knee Brace for patellofemoral and multicompartment osteoarthritis, the Adonis Joint Distraction Knee Brace for unicompartmental osteoarthritis, and solutions for post-operative recovery, neurological conditions, and complex lower extremity mobility challenges.
"Our health system's mission is to serve all persons with the greatest care and love. As we evaluated Icarus Medical, we needed to be confident that its solutions could meaningfully improve the lives of the patients we serve, said Ben Spektor, director of Venture Investments at OSF Ventures. “Through engagement with our clinicians, we quickly validated that conviction and received strong feedback regarding both the significant unmet need and the value of Icarus' innovative bracing technology. Spektor added, “Icarus is at the forefront of bracing innovation, and we are proud to support the company's growth while helping expand access to its products across our Ministry.”
Icarus Medical designs and manufactures its products in Charlottesville, Virginia, while continuing to advance its manufacturing capabilities and create new local jobs. Over the past year, Icarus Medical was named to the Inc. 5000 list of America’s fastest-growing private companies after achieving 1,283% three-year growth. The company was also recently recognized with the 2026 CBIC Startup of the Year Award by the Charlottesville Business Innovation Council.
About Icarus Medical
Icarus Medical is a Charlottesville, Virginia-based medical technology company focused on developing innovative orthopedic bracing solutions that help patients stay active, improve mobility, and reduce pain. The company combines biomechanics, software, and additive manufacturing to create advanced orthopedic technologies for osteoarthritis, post-operative recovery, neurological conditions, and lower extremity mobility challenges.
For more information about Icarus Medical, visit https://icarusmedical.com.
John Hipsher
Icarus Medical
+1 888-492-1101
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Back in Motion: A Veteran's Journey with the Ascender Knee Brace
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

